NSC 23766 Trihydrochloride
Selleck Chemicals
SKU:S8031-10MG
Couldn't load pickup availability
NSC 23766 Trihydrochloride is an inhibitor of Cdc42 used in studies of target-focused biology. It is especially relevant in cancer, cell cycle, and cell signaling models, where defined compound exposure can be linked to annotated target biology and downstream cellular responses.
By inhibiting Cdc42, NSC 23766 Trihydrochloride can be used to examine annotated target biology and downstream cellular responses. That positioning is consistent with concentration-response inhibition and target-dependence studies and with follow-up studies that compare concentration-dependent responses across orthogonal assay formats. In cancer, cell cycle, and cell signaling models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving Cdc42
- Concentration-response inhibition and target-dependence studies
- Phenotypic profiling in cancer, cell cycle, and cell signaling models
- Combination studies with orthogonal perturbagens
Overall, NSC 23766 Trihydrochloride is appropriate when a defined chemical perturbant is needed to connect Cdc42 with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, cell cycle, and cell signaling models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- Cdc42
- Target Class:
- Other
- Research Area:
- Cancer • Cell Cycle • Cell Signaling
- CAS No.:
- 1177865-17-6
- Molecular Weight:
- 530.97
- Formula:
- C₂₄H₃₅N₇·3ClH
- SMILES:
- CCN(CC)CCCC(C)NC1=NC(=CC(=N1)NC2=CC3=C(C=C(N=C3C=C2)C)N)C.Cl.Cl.Cl
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.